ChromaDex
CDXC
$3.30
Share price
-5.17%
Change (1 day)
112.90%
Change (1 year)
Categories
P/S ratio for ChromaDex (CDXC)
P/S ratio as of May 2024 (TTM): 3.15
According to ChromaDex's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.14557. At the end of 2023 the company had a P/S ratio of 1.29.
P/S ratio history for ChromaDex from 2009 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 1.29 | -25.97% |
| 2022 | 1.74 | -54.03% |
| 2021 | 3.78 | -24.64% |
| 2020 | 5.01 | -9.61% |
| 2019 | 5.55 | -7.38% |
| 2018 | 5.99 | -59.9% |
| 2017 | 14.9 | 206.35% |
| 2016 | 4.87 | -19.4% |
| 2015 | 6.05 | -1.7% |
| 2014 | 6.15 | -60.66% |
| 2013 | 15.6 | 271.75% |
| 2012 | 4.21 | -16.85% |
| 2011 | 5.06 | -53.22% |
| 2010 | 10.8 | 392.39% |
| 2009 | 2.20 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Sangamo Therapeutics
SGMO | 0.7167 | -77.21% | 🇺🇸 USA |
 Exelixis EXEL | 3.35 | 6.46% | 🇺🇸 USA |